Navigation Links
Azantis Launches Liposomal Glutathione and Vitamin C.
Date:10/31/2011

BOULDER, Colo., Oct. 31, 2011 /PRNewswire/ -- Azantis launched today two innovative liposomal products: reduced glutathione and vitamin C. Both oral supplements are formulated in liposomal form to maximize absorption and to minimize side effects. Azantis, a leading phospholipid manufacturer, markets the liposomal products to resellers targeting the health care practitioner channel.

The liposomal glutathione contains 500 mg reduced glutathione per recommended daily dose.  These liposomes are highly stable with a very tight particle size range.  These features optimize the bioavailability of the glutathione cargo.

Glutathione is the body's most important intracellular sulfur bearing antioxidant, and the body's prime defense against toxins and oxidation. Low glutathione blood levels are commonly associated with poor health.

The vitamin C liposomes are designed to minimize intestinal discomfort, since certain individuals have difficulty tolerating vitamin C therapy at the clinically relevant higher doses. The recommended daily dosage is 1,000 mg vitamin C.  The vitamin C, as well as the glutathione liposomal product, is in liquid form.

"Reduced glutathione in liposomal form is superior, because of the maximized absorption. Oral administration of supplemental liposomes, when compared to IV and injections, allows a more even dosing of once or possibly several times per day," said Mickey Schuett, Director of Sales at Azantis Inc. "These products target foremost health care practitioners and resellers that market to these practitioners. The potency of this advanced delivery form is less suitable for the direct to consumer market."

Consumer information about liposomal glutathione and liposomal vitamin C can be readily found on the internet.

About Azantis

Azantis is a biotech company located in Boulder, Colorado. The company specializes in discovery and extraction of bioactive molecules from sustainable marine and other biomass sources for use in food, nutraceutical, and pharmaceutical products. Azantis' product offerings include omega 3 phospholipids and phospholipid liposomes.

Contact Mickey Schuett, 303-502-2400 or http://www.azantis.com/contact-us/


'/>"/>
SOURCE Azantis
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Azantis Announces New Consumer Safety Program
2. Australias Prince of Wales Hospital Launches New Era of Targeted Lung Cancer Treatments with Elektas Advanced 4D Motion Management Technology
3. Global Strategic Marketing Key to Success in Oncology Launches in the Pharmaceutical Sector
4. FHSSA Launches New Campaign to Partner US Hospices with Programs in Sub-Saharan Africa
5. nContact, Inc. Launches New Corporate Websites
6. First Response Launches IVF Fundraising Resource for Those Trying for a Baby
7. CDC Launches Effort to Protect Cancer Patients From Infections
8. Mylan Launches First Generic Version of Exelon® Capsules in the U.K.
9. Gamma Pharmaceuticals, Inc., Launches Retail Promotions for Gamma Energy Gel™ in New York City and Houston
10. Arthrosurface Launches Worlds First Talus Resurfacing Implant for the Ankle
11. DYMO® Labeling Launches High-Resolution Identification Scanner for Health Records Processing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2017)... , Sept. 12, 2017  Consumer reviews on the independent review ... as the number one company for hearing aids, ranking it higher ... other brands. ... Named #1 by Consumers For Hearing Aids ... Embrace Hearing is an online store that provides high performance, state-of-the-art, ...
(Date:9/9/2017)... , Sept. 8, 2017 ... Mobile MRI Unit coming to Washington DC ... When: Tuesday, September 12 th – Monday, September 18 ... D.C. offering free MRI brain scans to the public.Where:  ... be parked at 501 K Street NW, Washington, D.C.What:BTF brings its nationwide ...
(Date:9/9/2017)... 2017  Eli Lilly and Company (NYSE: ... data for lasmiditan, an investigational, oral, first-in-class molecule for ... improvements compared to placebo in the Phase 3 SPARTAN ... 18th Congress of the International Headache Society (IHC) in ... presented today demonstrate lasmiditan,s potential to reduce pain and ...
Breaking Medicine Technology:
(Date:9/19/2017)... ... September 19, 2017 , ... Peter ... the President’s Malaria Initiative (PMI) Africa Indoor Residual Spraying (AIRS) Project , ... , The Innovation to Action Award, a USAID Catalyst Award, recognizes USAID ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... exclusively to funding innovative lymphoma research and serving the lymphoma community through a ... to Texas as a part of its national Swirl: A Wine Tasting Event ...
(Date:9/19/2017)... ... September 19, 2017 , ... The American College of ... its recently formed Corporate Roundtable, a group of individuals and organizations whose collective ... , Canyon Ranch is a unique collection of lifestyle-based immersion vacation settings and ...
(Date:9/19/2017)... ... September 19, 2017 , ... The American Board of Multiple ... for the discomforts and hidden dangers of foot fungus, particularly in the warm ... risk for developing fungal infections on the feet or toenails, the Board says. ...
(Date:9/19/2017)... ... September 19, 2017 , ... Leonard I. Linkow, DDS, DMSC, sets a new ... Xlibris on July of 2014). This book details the recent advances and techniques in ... benefit people who have lost all of their natural teeth . , In ...
Breaking Medicine News(10 mins):